Cardiff Oncology
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $109 | $120 | $121 | $109 |
Gross Profit | 109 | 120 | -11,459 | 109 |
EBITDA | -6,989 | -10,764 | -14,683 | -14,154 |
EBIT | -7,217 | -11,258 | -14,777 | -14,382 |
Net Income | -7,217 | -11,258 | -13,943 | -13,434 |
Net Change In Cash | 109 | 120 | 121 | 109 |
Free Cash Flow | -5,967 | -10,852 | -8,353 | -12,794 |
Cash | 17,470 | 10,135 | 10,784 | 24,095 |
Basic Shares | 66,841 | 66,879 | 66,526 | 47,650 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $593 | $683 | $488 | $386 |
Gross Profit | -311 | 683 | 488 | 386 |
EBITDA | -44,972 | -48,247 | -45,014 | -39,666 |
EBIT | -45,876 | -48,651 | -45,412 | -39,902 |
Net Income | -45,876 | -45,431 | -41,441 | -38,704 |
Net Change In Cash | 593 | 683 | 488 | 386 |
Cost of Revenue | 4,404 | |||
Free Cash Flow | -37,967 | -37,773 | -31,469 | -34,712 |
Cash | 17,470 | 51,470 | 21,655 | 16,347 |
Basic Shares | 66,841 | 47,650 | 44,677 | 43,600 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.11 |
2025-09-30 | -$0.17 |
2025-06-30 | -$0.21 |
